“Jerky assessment.” No, his assessment is l
Post# of 148184
(Total Views: 644)
Posted On: 07/06/2020 2:53:34 PM
Re: Bobbythebus #41296
“Jerky assessment.”
No, his assessment is logical. If you read the posts from this past weekend discussing the White House’s potential announcement this week, you’d understand why many don’t believe leronlimab will be mentioned.
The main reason is that the data from the M2M and severe trial have not been analyzed yet per Dr. NP’s interview on Saturday night. That means it’s impossible that the White House could know leronlimab is showing efficacy in clinical trials.
Now, could the White House mention leronlimab as a potential treatment and that it’s shown promising results. Yes, but I don’t see that happening. This is a political game, hence why the White House is making COVID19 announcements and not the CDC/NIH, and I don’t think CYDY is quite in the political game yet, but BP is and they have a lot of power to push their product.
No, his assessment is logical. If you read the posts from this past weekend discussing the White House’s potential announcement this week, you’d understand why many don’t believe leronlimab will be mentioned.
The main reason is that the data from the M2M and severe trial have not been analyzed yet per Dr. NP’s interview on Saturday night. That means it’s impossible that the White House could know leronlimab is showing efficacy in clinical trials.
Now, could the White House mention leronlimab as a potential treatment and that it’s shown promising results. Yes, but I don’t see that happening. This is a political game, hence why the White House is making COVID19 announcements and not the CDC/NIH, and I don’t think CYDY is quite in the political game yet, but BP is and they have a lot of power to push their product.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼